Advisory Board

jeffreyJeffrey A. Gelfand, MD, Ph.D

Dr. Jeffrey A. Gelfand, serves as a Chairman of the Scientific Advisory Board. Dr. Jeffrey A. Gelfand is a Professor and Chairman of the Department of Medicine at Tufts and Physician-in-Chief at the New England Medical center. He is currently an attending physician at Massachusetts General Hospital, a Clinical Professor at Harvard Medical School, and Professor of Medicine at Tufts. Dr. Gelfand conducts laboratory and clinical research in immunology, inflammation, infection, and tumor immunology.

michaelMichael Cynamon, MD, Ph.D

Dr, Cynamon serves as a Member of Scientific Advisory Board. Dr. Michael Cynamon is an infectious disease specialist in Syracuse, New York and is affiliated with Syracuse Veterans Affairs Medical Center. He received his medical degree from Yale University School of Medicine and has been in practice for 43 years.

He is a leading researcher in pulmonary infections with more than 35 years experience in healthcare research.

victortVictor Tetz, MD, Ph.D

Dr. Tetz  serves as Scientific Advisor and is responsible for the strategic planning for TGV Therapeutics. Senior Investigator and Group Leader in Microbiology Research for the company conducting research for Pepsi, Gen3Partners, Dole and others. Member of the American Society for Microbiology.



georgeGeorge Tetz, MD, Ph.D

Dr. Tetz  serves as CEO and as Senior Director Clinical Development.




Michelle-Welborn116x145 (2)
Dr. Michelle Welborn

Dr. Michelle Welborn, serves as a pharmaceutical consultant and provides regulatory consulting to manage the project in FDA. Michelle Welborn holds a Doctor of Pharmacy degree from Campbell University School of Pharmacy. Michelle has 15 years experience in pharmaceuticals as a liaison in Medical and Regulatory Affairs for both Astra-Merck and Sanofi –Aventis Pharmaceuticals, and as Clinical Pharmacy Manager for a Health Maintenance Organization (HMO) , and as a Pharmacy Practice resident at Wake Forest University Baptist Medical Center

She has participated in workshops and consortiums organized by the NIH (National Institutes of Health), the National Organization of Rare Diseases (NORD), the International Congress of Rare Diseases (ICORD), and the Centers for Disease Control (CDC), the Epilepsy Foundation of America, and the Australian Dravet syndrome Family Day. She served for two years as the Professional Advisory Board Chair for the IDEA League before founding ICE. She currently serves on the Professional Advisory Boards for the Charlie Foundation and Lennox-Gastaut Syndrome Foundation.